Evidence level: C
一个只有 1 个自由度的检验,装不下「要不要拆成两个构造」这个问题。
正文
上一轮问的是「12 格够不够判方向」,这一轮问得更靠前一层:%AB、CoV、φ、X5 这四个参数,到底该算 1 个构造,还是 2 个构造。 设想的研究很干净——大样本横断面同步采四个参数,做二因子模型,看它是否显著优于单因子。但这套设计拆成算术就露馅:四指标、每构造两个,自由度只剩 1 个。一个自由度,要去回答一个关于「世界上有几个东西」的问题。 这不是样本量不够,是模型装不下问题。
先把账算清。四个指标提供 4×5/2=10 个已知量。二因子相关模型需要估:2 个载荷(另 2 个固定为 1 以定标)、4 个误差方差、2 个因子方差、1 个因子间相关,共 9 个。10−9=1。单因子版本则是 3 个载荷加 4 个误差加 1 个因子方差,共 8 个,df=2。所以「二因子 vs 单因子」的 χ² 差检验只有 1 个自由度:它只能答一道是非题,而且答错的方式不对称。
不对称在哪里?二指标因子的识别规则有个附加条件:该因子必须与模型中另一个因子有非零相关。翻成大白话——只有当两个构造确实相关时,这个模型才估得出来。若真答案是「两者无关」,每个因子只剩两个指标、相关为零,模型当场经验不可识别。而纵向 CFA 的通用要求本来就写明:每个潜变量至少三个指标才可识别,两个指标的模型「不可估」(PMID 41511670)。于是这个检验只在中度相关那一段能跑通:真值靠近 0 时估不出来,靠近 1 时又出不当解。它恰好只在你不必问的区间里工作。
真答案是「一个构造」时,二因子模型也不会礼貌地失败。它给出的是不当解:负误差方差、载荷大于 1、或者干脆不收敛——而软件报的是「估计问题」,不是「你的二因子假设被推翻」。后果是研究者去修它:删掉一个指标、让两个误差项相关、或者换个参数化。代谢综合征那组八指标三模型就是活教材:青春期模型直接不收敛,其余阶段反复出 Heywood case,删了离群值也不解决(PMID 19732562)。更要紧的一条是:若真相关矩阵本身就蕴含不当解,加大样本只会让它更常出现(PMID 36875295)。所以「再招点人」这条路,方向是反的。
还有一层方法混淆。%AB 与 φ 都出自同一台 RIP、同一次佩戴、同一次校准;CoV 来自 EIT,X5 来自 FOT。也就是说,那个唯一自由度所检验的跨构造相关(%AB×φ),恰恰是同一方法内部的相关。按多质多法模型的结构,同方法相关只能往上加,不会往下减,它把「一个构造」这个方向推得更像。但反方也有硬证据:直接测过的研究没能支持「相同作答格式会显著虚高收敛效度」(PMID 30284857);而共同方法方差与模型设定错误在实践中常常分不开(PMID 10908073)。两边一起摆:这一格的相关不能当「构造重叠」的干净证据,可也不能一口咬定它是假的。
检验力这一关同样过不去。按 n=120、1 个自由度算,若真模型与单因子的差距是 ΔRMSEA=0.10,检验力只有 19.5%;要到 80%,样本量得约 785。所以「χ² 不显著 → 判一个因子」在这个规模下等于没测。相关侧更直白:n=120 时 Fisher z 区间半宽 0.181,真值 0.86 的 95% 区间上界正好压在 0.900;要宣称「相关低于 0.90」,真值至多 0.859。也就是说,n=120 只在共享方差已达 74% 时,才勉强说得上「没到 0.9」。
出路不是加人,是加指标和加方法。把指标扩到 6 个(3+3,df=8),或者让每个构造各由两种方法测;并且预注册一条退化处理规则:出现不当解时不许删指标、不许放误差相关,必须原样记为「二因子不可估」。三格判据:① 六指标 3+3、Δχ² 显著且两因子相关的 95% 区间上界低于 0.85 → 拆成两构造成立,「三模态同向」命题废止,改为分别验证;② 区间含 1.0 或出现不当解 → 不许宣布「一个构造」,只能写「在当前指标数下不可分辨」,转做单构造内部的多方法验证;③ Δχ² 不显著但检验力低于 0.5 → 记为「未检出」,不得记为「单因子被支持」。须自认:0.85 与 0.5 两个门槛无出处,须由本队列的等效界反解替换。另外,即便建成二因子,能不能比均值还另说——标量不变性在实践中只是可逼近的理想(PMID 28080078),而违反它会让潜在的组间差异虚高到 63% 的假阳性率(PMID 34997192);模型错配时常用拟合指标往往也检不出来(PMID 26283977),双因子与二阶因子在杂质多时同样难分(PMID 29230085、PMID 35677113)。
证据与局限
已验证:每个潜变量至少三个指标才可识别,两指标模型不可估(PMID 41511670);四指标二因子相关模型的自由度为 1 而单因子为 2,Δχ² 只有 1 个自由度,是我们自算的代数结论;大型因子模型反复出现不收敛与 Heywood case,且删离群值无效(PMID 19732562);样本量增大不能消除不当解、反而增加其出现概率(PMID 36875295);模型错配时指标常检不出(PMID 26283977);标量不变性是理想而非现状(PMID 28080078),违反它可使潜在组间差异的假阳性率达 63%(PMID 34997192)。
部分验证:共同方法方差会虚高相关的结构性推论成立,但一项直接检验未发现有意义增幅(PMID 30284857),与共同方法方差和设定错误难分(PMID 10908073)一起看,只能判「方向可能被推、幅度未定」。双因子与二阶因子的可分辨性随未建模复杂度上升而下降(PMID 29230085、PMID 35677113),提示任何「拆成两个」的胜利都可能只是模型更松。
待验证:① 丹田四参数的跨构造相关里有多大来自 RIP 这一共同方法,从未拆过;② 六指标 3+3 方案下四个参数的因子归属是否稳定;③ 「腹式化」「协调化」两个词是否只是给两组参数起了名字,而非发现了两个机制。
L1 网络状态:边表止于 E-050(「六十甲子纳音 ↔ 60 个频率」,L1、open,现代证据栏原文「尚无任何可测来源」);节点表生理侧仅登记「呼吸率 / 呼吸模式|可穿戴」,无「腹式化 / 协调化」等构造字段,全表逐词检索「构造 / 因子 / 效度 / 不变 / 多质」均 0 命中——该主题尚未进入 L1 对应网络。
相关阅读
证据等级: C
参考文献: PMID 41511670, PMID 19732562, PMID 36875295, PMID 26283977, PMID 30284857, PMID 10908073, PMID 28080078, PMID 34997192, PMID 29230085, PMID 35677113
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
\”Abdominalization\” and \”Coordination\”: The Arithmetic Truth of Two Constructs Supported by Only Four Indicators
Evidence level: C
A test with only 1 degree of freedom cannot accommodate the question of “whether to split into two constructs.”
Main Text
The previous round asked whether “12 cells are enough to judge direction”; this round asks a layer deeper: whether %AB, CoV, φ, and X5 should be calculated as 1 construct or 2 constructs. The envisioned study is clean—large-sample cross-sectional simultaneous measurement of four parameters, two-factor model, testing whether it significantly outperforms the single-factor. But this design, when broken down arithmetically, reveals the flaw: four indicators, two per construct, leaves only 1 degree of freedom. One degree of freedom is insufficient to answer a question about “how many things exist in the world.” This is not a matter of insufficient sample size; it is a matter of the model being unable to accommodate the question.
Let us balance the accounts. Four indicators provide 4×5/2 = 10 known quantities. A two-factor correlation model requires estimation of: 2 loadings (the other 2 fixed at 1 for scaling), 4 error variances, 2 factor variances, and 1 inter-factor correlation, totaling 9. 10 − 9 = 1. The single-factor version has 3 loadings plus 4 errors plus 1 factor variance, totaling 8, df = 2. Thus, the χ² difference test for “two-factor vs single-factor” has only 1 degree of freedom: it can answer only one yes/no question, and the way it fails is asymmetric.
Where does the asymmetry lie? The identification rule for two-indicator factors has an additional condition: the factor must have non-zero correlation with another factor in the model. In plain terms—only when two constructs are indeed correlated can this model be estimated. If the true answer is “they are unrelated,” each factor has only two indicators, correlation zero, and the model becomes empirically unidentified. The general requirement for longitudinal CFA explicitly states: each latent variable must have at least three indicators to be identified; a two-indicator model is “unestimable” (PMID 41511670). Thus, this test works only in the moderate correlation range: it cannot estimate when the true value is near 0, and produces improper solutions when near 1. It operates exactly in the interval you do not need to ask about.
When the true answer is “one construct,” the two-factor model does not politely fail. It yields improper solutions: negative error variances, loadings greater than 1, or outright non-convergence—while the software reports “estimation problems,” not “your two-factor hypothesis was refuted.” Consequently, researchers attempt to fix it: remove an indicator, correlate two error terms, or change parameterization. The metabolic syndrome set of eight indicators and three models serves as a textbook example: the puberty model failed to converge entirely, while other stages repeatedly produced Heywood cases; removing outliers did not resolve it (PMID 19732562). More critically: if the true correlation matrix itself implies improper solutions, increasing the sample size only makes them more frequent (PMID 36875295). Thus, “recruiting more people” is the wrong direction.
There is also methodological confusion. %AB and φ both originate from the same RIP, same wearing session, same calibration; CoV comes from EIT, X5 from FOT. That is, the only degree of freedom testing cross-construct correlation (%AB×φ) is actually correlation within the same method. According to the structure of multitrait-multimethod models, same-method correlations can only increase, never decrease; it pushes the “one construct” direction even more strongly. Yet counter-evidence exists: direct measurement studies failed to support “same response format significantly inflates convergent validity” (PMID 30284857); and common method variance and model misspecification are often inseparable in practice (PMID 10908073). Putting both sides together: this cell’s correlation cannot be taken as clean evidence of “construct overlap,” nor can it be definitively declared false.
Power is also insufficient. With n = 120 and 1 degree of freedom, if the true difference between models is ΔRMSEA = 0.10, power is only 19.5%; to reach 80%, sample size must be approximately 785. Thus, “χ² not significant → conclude one factor” in this scale is equivalent to no measurement. The correlation side is more direct: at n = 120, Fisher z interval half-width is 0.181; the upper bound of the 95% interval for true value 0.86 is exactly 0.900; to claim “correlation below 0.90,” true value must be at most 0.859. That is, n = 120 can only weakly claim “not reaching 0.9” when shared variance is already 74%.
The solution is not adding people, but adding indicators and methods. Expand indicators to 6 (3+3, df = 8), or have each construct measured by two methods; and preregister a degradation rule: when improper solutions occur, do not remove indicators, do not correlate error terms; record them as “two-factor unestimable.” Three-cell criteria: ① Six indicators 3+3, Δχ² significant and upper bound of 95% CI for two-factor correlation < 0.85 → splitting into two constructs holds, “trimodal directionality” hypothesis abolished, replaced by separate validation; ② Interval contains 1.0 or improper solutions appear → cannot declare “one construct,” must write “unresolvable under current indicator count,” proceed with multimethod validation within single construct; ③ Δχ² not significant but power < 0.5 → record as “not detected,” do not record as “single-factor supported.” Must acknowledge: thresholds 0.85 and 0.5 have no source; must be replaced by equivalent bounds derived from this cohort. Furthermore, even if two-factor is established, whether it exceeds mean invariance remains uncertain—scalar invariance in practice is only an ideal approximation (PMID 28080078); violating it can inflate false positive rate of latent group differences to 63% (PMID 34997192); model misspecification often goes undetected by fit indices (PMID 26283977); two-factor and second-order factors are similarly hard to distinguish when complexity is high (PMID 29230085, PMID 35677113).
Evidence and Limitations
Verified: Each latent variable requires at least three indicators to be identified; two-indicator models are unestimable (PMID 41511670); four-indicator two-factor correlation model has df = 1 while single-factor has df = 2, Δχ² only 1 degree of freedom, which is our own algebraic conclusion; large factor models repeatedly show non-convergence and Heywood cases, and removing outliers is ineffective (PMID 19732562); increasing sample size does not eliminate improper solutions but increases their probability (PMID 36875295); model misspecification often goes undetected by indicators (PMID 26283977); scalar invariance is ideal rather than reality (PMID 28080078); violating it can inflate false positive rate of latent group differences to 63% (PMID 34997192).
Partially Verified: Common method variance does inflate structural correlation, but one direct test found no meaningful increase (PMID 30284857); combined with common method variance and model misspecification being inseparable (PMID 10908073), we can only conclude “direction may be pushed, magnitude undetermined.” Distinguishability of two-factor and second-order factors decreases with unmodeled complexity (PMID 29230085, PMID 35677113), suggesting any “split into two” victory may merely reflect looser modeling.
To Be Verified: ① How much of the cross-construct correlation among the four Dantian parameters originates from RIP, this common method, has never been decomposed; ② Under the six-indicator 3+3 scheme, whether factor assignment of four parameters remains stable; ③ Whether “abdominalization” and “coordination” are merely names given to two sets of parameters, rather than discoveries of two mechanisms.
L1 Network Status: Edge table ends at E-050 (“Sixty Jiazi Yin-Ying ↔ 60 frequencies”, L1, open, original text of modern evidence column states “no measurable source yet“); node table physiological side only registers “respiration rate / respiration pattern | wearable”, no construct fields such as “abdominalization / coordination”; full table word search for “construct / factor / validity / invariant / multitrait” yields 0 hits—this topic has not yet entered the L1 corresponding network.
Further Reading
- “The fact that ‘all three modalities shift in the same direction’ has never been verified”
- “The phrase ‘7/12’ says nothing: power floor of direction voting”
- “Sources of noise in Dantian respiratory trimodal measurement: posture, electrode belt, operator contribution decomposition”
- “Biofrequency Code (Research Pool P3)”
Evidence Level: C
References: PMID 41511670, PMID 19732562, PMID 36875295, PMID 26283977, PMID 30284857, PMID 10908073, PMID 28080078, PMID 34997192, PMID 29230085, PMID 35677113
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply